Antithrombotic Utilization Evaluation in Patients Suffering from Deep Vein Thrombosis at a Tertiary Care Teaching Hospital

    Published on:January 2018
    Journal of Young Pharmacists, 2018; 10(1):82-85
    Original Article | doi:10.5530/jyp.2018.10.19

    Chandresh B. Dumatar, Sandip S. Jadav, Aashutosh J. Patel

    Department of Pharmacology, B. J. Medical College, Ahmedabad, Gujarat, INDIA.


    Objective: To evaluate the usage pattern of antithrombotic in patients suffering from deep vein thrombosis (DVT) in a tertiary care teaching hospital. Methods: It was an observational, prospective and single centre study carried out over period of 18 months among the indoor patients suffering from DVT in department of Surgery, Orthopedics and Neurosurgery at a tertiary care teaching hospital. Results: Out of 26,687 indoor patients assessed for eligibility, only 32 (0.12%) patients were of DVT. Out of 32 patients of DVT, all the patients were prescribed anticoagulant drug whereas, 4 patients were prescribed both antiplatelet and anticoagulant. Only 2 patients were given aspirin as a single drug. No modification of antiplatelet therapy was observed. None of DVT patients had contraindication to use of anticoagulants. Only 4 patients developed bleeding during follow up. Conclusion: DVT treatment is very important and antithrombotic therapy is mainstay of treatment among patients of DVT. All patients of DVT received adequate antithrombotic therapy. Warfarin was most commonly used anticoagulant for DVT treatment.

    Key words: Antithrombotic, Deep vein thrombosis, Drug utilization.

    Article Download


    SCImago Journal & Country Rank